Evidence map›Paper›PMID 37867661›Full record

ArticleACS omega2023

Identification of a Potential Antimycobacterial Drug Sensitizer Targeting a Flavin-Independent Methylenetetrahydrofolate Reductase.

Jiacong Li, Yong Nian, Jian Liu, Mingxia Yang, Yuanling Jin, Xiaoman Kang, Haodong Xu, Zhuo Shang, Wei Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jiacong LiDepartment of Pathogen Biology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 210023 Nanjing, China.
Yong NianSchool of Pharmacy, Nanjing University of Chinese Medicine, 210023 Nanjing, China.
Jian LiuSchool of Pharmacy, Nanjing University of Chinese Medicine, 210023 Nanjing, China.ORCID https://orcid.org/0000-0001-9482-9036
Mingxia YangDepartment of Pathogen Biology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 210023 Nanjing, China.
Yuanling JinDepartment of Pathogen Biology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 210023 Nanjing, China.
Xiaoman KangCAS Key Laboratory of Synthetic Biology, Centre of Excellence for Molecular Plant Sciences, Chinese Academy of Sciences, 200032 Shanghai, China.
Haodong XuSchool of Pharmacy, Nanjing University of Chinese Medicine, 210023 Nanjing, China.
Zhuo ShangSchool of Pharmaceutical Sciences, Shandong University, 250100 Jinan, China.
Wei LinState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 200237 Shanghai, China.ORCID https://orcid.org/0000-0002-2940-6966
Nanjing University of Chinese Medicine · CNChinese Academy of Sciences · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing antibiotic resistance of

Identifiers

PMID37867661
PMCPMC10586308
OpenAlexW4387342615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.